doctors are worried about prescribing glp 1 GLP-1s to certain patients - University of Cincinnati: Founder of Co-op, Leader in Co-op Considering GLP-1 drugs for weight

Description

Review the need for prescribing a GLP-1 RA agent and stop treatment if no longer required due to not achieving desired clinical effect as per NICE CG28

Good experience Great product

In 2023, these drugs accounted for the majority of the growth in endocrine drug spending

Companies Sued For Ozempic or Other GLP-1 Injury Defendants named in GLP-1 injury lawsuits have included manufacturers, sellers and/or distributors of various GLP-1 receptor agonist medications, including: Novo Nordisk (Ozempic, Rybelsus, Wegovy, Saxenda) Eli Lilly (Mounjaro, Zepbound, Trulicity) Other GLP-1 injury defendants Ozempic GLP-1 Lawsuit & Settlement Updates Recent updates about Ozempic lawsuits and settlements include: July 2026: GLP-1 lawsuits remain active in federal and state courts